431 related articles for article (PubMed ID: 15178665)
1. Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study.
Vanky E; Salvesen KA; Heimstad R; Fougner KJ; Romundstad P; Carlsen SM
Hum Reprod; 2004 Aug; 19(8):1734-40. PubMed ID: 15178665
[TBL] [Abstract][Full Text] [Related]
2. Six-month treatment with low-dose dexamethasone further reduces androgen levels in PCOS women treated with diet and lifestyle advice, and metformin.
Vanky E; Salvesen KA; Carlsen SM
Hum Reprod; 2004 Mar; 19(3):529-33. PubMed ID: 14998946
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine levels are unaffected by metformin treatment in both nonpregnant and pregnant women with polycystic ovary syndrome.
Carlsen SM; Kjøtrød S; Vanky E; Romundstad P
Acta Obstet Gynecol Scand; 2007; 86(2):145-50. PubMed ID: 17364275
[TBL] [Abstract][Full Text] [Related]
4. Metformin influence on hormone levels at birth, in PCOS mothers and their newborns.
Carlsen SM; Vanky E
Hum Reprod; 2010 Mar; 25(3):786-90. PubMed ID: 20023292
[TBL] [Abstract][Full Text] [Related]
5. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome.
Glueck CJ; Bornovali S; Pranikoff J; Goldenberg N; Dharashivkar S; Wang P
Diabet Med; 2004 Aug; 21(8):829-36. PubMed ID: 15270785
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone concentrations in androgen-suppressed women with polycystic ovary syndrome.
Carlsen SM; Vanky E; Fleming R
Hum Reprod; 2009 Jul; 24(7):1732-8. PubMed ID: 19342396
[TBL] [Abstract][Full Text] [Related]
7. Metformin treatment before IVF/ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study.
Kjøtrød SB; von Düring V; Carlsen SM
Hum Reprod; 2004 Jun; 19(6):1315-22. PubMed ID: 15117902
[TBL] [Abstract][Full Text] [Related]
8. Metformin has no major effects on glucose homeostasis in pregnant women with PCOS: results of a randomized double-blind study.
Fougner KJ; Vanky E; Carlsen SM
Scand J Clin Lab Invest; 2008; 68(8):771-6. PubMed ID: 18651320
[TBL] [Abstract][Full Text] [Related]
9. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?
Nawaz FH; Khalid R; Naru T; Rizvi J
J Obstet Gynaecol Res; 2008 Oct; 34(5):832-7. PubMed ID: 18834342
[TBL] [Abstract][Full Text] [Related]
10. Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.
Baillargeon JP; Jakubowicz DJ; Iuorno MJ; Jakubowicz S; Nestler JE
Fertil Steril; 2004 Oct; 82(4):893-902. PubMed ID: 15482765
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine levels in women with polycystic ovary syndrome treated with metformin versus rosiglitazone: a randomized study.
Kilicdag EB; Bagis T; Zeyneloglu HB; Tarim E; Aslan E; Haydardedeoglu B; Erkanli S
Hum Reprod; 2005 Apr; 20(4):894-9. PubMed ID: 15618250
[TBL] [Abstract][Full Text] [Related]
12. A randomized, 48-week, placebo-controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study.
Hoeger KM; Kochman L; Wixom N; Craig K; Miller RK; Guzick DS
Fertil Steril; 2004 Aug; 82(2):421-9. PubMed ID: 15302293
[TBL] [Abstract][Full Text] [Related]
13. Effects of metformin on insulin resistance, androgen concentration, ovulation and pregnancy rates in women with polycystic ovary syndrome following laparoscopic ovarian drilling.
Kocak I; Ustün C
J Obstet Gynaecol Res; 2006 Jun; 32(3):292-8. PubMed ID: 16764619
[TBL] [Abstract][Full Text] [Related]
14. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
[TBL] [Abstract][Full Text] [Related]
15. Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome.
Nawaz FH; Rizvi J
Gynecol Obstet Invest; 2010; 69(3):184-9. PubMed ID: 20029224
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
17. The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications.
De Leo V; Musacchio MC; Piomboni P; Di Sabatino A; Morgante G
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):63-6. PubMed ID: 21530058
[TBL] [Abstract][Full Text] [Related]
18. Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy.
Kovo M; Weissman A; Gur D; Levran D; Rotmensch S; Glezerman M
J Matern Fetal Neonatal Med; 2006 Jul; 19(7):415-9. PubMed ID: 16923696
[TBL] [Abstract][Full Text] [Related]
19. Effect of metformin administration on plasma advanced glycation end product levels in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Alexandraki K; Piperi C; Aessopos A; Paterakis T; Katsikis I; Panidis D
Metabolism; 2007 Jan; 56(1):129-34. PubMed ID: 17161235
[TBL] [Abstract][Full Text] [Related]
20. Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome.
Glueck CJ; Pranikoff J; Aregawi D; Wang P
Fertil Steril; 2008 Mar; 89(3):625-34. PubMed ID: 17678910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]